These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8741945)

  • 1. Movements in never-medicated schizophrenics: a preliminary study.
    Fenn DS; Moussaoui D; Hoffman WF; Kadri N; Bentounssi B; Tilane A; Khomeis M; Casey DE
    Psychopharmacology (Berl); 1996 Jan; 123(2):206-10. PubMed ID: 8741945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lack of involuntary abnormal movements in untreated schizophrenic patients].
    Hernán Silva I; Jerez CS; Ruiz TA; Seguel LM; Court LJ; Labarca BR
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(5):200-2. PubMed ID: 7817846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy for a patient with persistent tardive dyskinesia: a case report and literature review.
    Peng LY; Lee Y; Lin PY
    J ECT; 2013 Sep; 29(3):e52-4. PubMed ID: 23965612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for spontaneous dyskinesia in schizophrenia.
    Fenton WS; Wyatt RJ; McGlashan TH
    Arch Gen Psychiatry; 1994 Aug; 51(8):643-50. PubMed ID: 8042913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders.
    Ayehu M; Shibre T; Milkias B; Fekadu A
    BMC Psychiatry; 2014 Oct; 14():280. PubMed ID: 25298069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area.
    Gervin M; Browne S; Lane A; Clarke M; Waddington JL; Larkin C; O'Callaghan E
    Am J Psychiatry; 1998 Sep; 155(9):1202-6. PubMed ID: 9734543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of abnormal involuntary movements among chronic schizophrenics.
    Guy W; Ban TA; Wilson WH
    Int Clin Psychopharmacol; 1986 Apr; 1(2):134-44. PubMed ID: 3571941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.
    Zhou N; Yu Q; Li X; Yu Y; Kou C; Li W; Xu H; Luo X; Zuo L; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2013 May; 28(3):230-7. PubMed ID: 23559427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and deficit schizophrenia.
    Telfer S; Shivashankar S; Krishnadas R; McCreadie RG; Kirkpatrick B
    Acta Psychiatr Scand; 2011 Nov; 124(5):357-62. PubMed ID: 21838740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorder in never and minimally treated Nigerian schizophrenic patients.
    McCreadie RG; Ohaeri JU
    Br J Psychiatry; 1994 Feb; 164(2):184-9. PubMed ID: 7909712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous dyskinesia in first episode schizophrenia.
    Puri BK; Barnes TR; Chapman MJ; Hutton SB; Joyce EM
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):76-8. PubMed ID: 9886457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
    Owens DG; Johnstone EC; Frith CD
    Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
    Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.